Deep and Durable Cytogenetic and Molecular Responses with Pemigatinib in Myeloid/Lymphoid Neoplasms with Fibroblast Growth Factor Receptor 1 Rearrangement: The Fight-203 Study
Year: 2023
Type: conference-abstract
Source: Blood
Authors: Andreas Reiter, Jean-Jacques Kiladjian, Jay L. Patel, William Shomali, Alessandro Rambaldi, Srdan Verstovsek, Stephen Oh, Kensuke Usuki, Claire N Harrison, Ellen K. Ritchie, Luke P. Akard, Juan Carlos Hernandez Boluda, Françoise Huguet, Natalia Oliveira, Huiling Zhen, Tracy I. George, Philomena Colucci, Aidan Gilmartin, Jason Gotlib, Alessandro M. Vannucchi
Institutions: University Medical Centre Mannheim, Hôpital Saint-Louis, University of Utah, ARUP Laboratories (United States), Stanford Medicine, Stanford Cancer Institute, Stanford University, University of Milan, Ospedale Papa Giovanni XXIII, The University of Texas MD Anderson Cancer Center, Washington University in St. Louis, NTT Medical Center, Guy's and St Thomas' NHS Foundation Trust, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center, Franciscan Health Indianapolis, Hospital Clínico Universitario de Valencia, Centre Hospitalier Universitaire de Toulouse, Incyte (United States), Azienda Ospedaliero-Universitaria Careggi
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4389229521